Balyasny Asset Management L.P.

Position in VSTM — Verastem, Inc.

CIK 1218710 Chicago, IL

Position in VSTM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,171,828

-$22,499,176 QoQ

Shares Held

409,779

-87.2% QoQ

Ownership

0.466%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Balyasny Asset Management L.P. holds $2,162,785,356 across 177 Biotechnology names. VSTM ranks #115 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	2,779,445	$146,532,340
2	ERAS	Erasca, Inc.	5,143,985	$83,229,677
3	TNGX	Tango Therapeutics, Inc.	3,826,659	$80,053,706
4	APLS	Apellis Pharmaceuticals, Inc.	1,917,501	$77,141,065
5	BMRN	Biomarin Pharmaceutical Inc	1,362,752	$76,981,860
6	CYTK	Cytokinetics Inc	992,545	$65,418,640
7	DAWN	Day One Biopharmaceuticals, Inc.	2,625,235	$56,285,038
8	FOLD	AMICUS THERAPEUTICS, INC.	3,827,513	$55,345,837

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,171,828	409,779	-87.2%	Shares	Sole	2026-05-15
2025-12-31	$24,671,004	3,195,726	-22.9%	Shares	Sole	2026-02-17
2025-09-30	$36,615,908	4,146,762	-27.5%	Shares	Sole	2025-11-14
2025-09-30	$50,491,617	5,718,190	-1.0%	Shares	Sole	2025-11-14
2025-06-30	$23,976,193	5,777,396	+37.4%	Shares	Sole	2025-08-14
2025-06-30	$17,454,767	4,205,968	-12.2%	Shares	Sole	2025-08-14
2025-03-31	$28,871,489	4,787,975	0.0%	Shares	Sole	2025-05-15
2025-03-31	$28,871,489	4,787,975	+21.3%	Shares	Sole	2025-05-15
2024-12-31	$20,400,442	3,945,927	0.0%	Shares	Sole	2025-02-14
2024-12-31	$20,400,442	3,945,927	+12839.2%	Shares	Sole	2025-02-14
2024-03-31	$359,852	30,496	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.